Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age
This review aimed to assess the efficacy, effectiveness and safety of cell-based trivalent and quadrivalent influenza vaccines for the prevention of laboratory-confirmed influenza.
This Academic Publication is available from
Date of publication:
08 Fea 2022
Authors:
Karen Jordan, Eamon O. Murchu, Laura Comber, Sarah Hawkshaw, Liam Marshall, Michelle O’Neill, Conor Teljeur, Patricia Harrington, Annasara Carnahan, Jaime Jesús Pérez-Martín, Anna Hayman Robertson, Kari Johansen, Jorgen de Jonge, Tyra Krause, Nathalie Nicolay, Hanna Nohynek, Ioanna Pavlopoulou, Richard Pebody, Pasi Penttinen, Marta Soler-Soneira, Ole Wichmann, Máirín Ryan
Journal:
Reviews in Medical Virology
Digital object identifier:
DOI: 10.1002/rmv.2332
Type of output:
Evidence synthesis
Suggested Citation:
Jordan K, Murchu EO, Comber L, Hawkshaw S, Marshall L, O’Neill M, Teljeur C, Harrington P, Carnahan A, Pérez-Martín JJ, Hayman Robertson A, Johansen K, de Jonge J, Krause T, Nicolay N, Nohynek H, Pavlopoulou I, Pebody R, Penttinen P, Soler-Soneira M, Wichmann O & Ryan M. Systematic review of the efficacy, effectiveness and safety cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age. Reviews Medical Virology. 2022;e2332.